Allergy and Immunology · Jackson, MS
NPI
1629056502
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1513 Lakeland Dr., Suite 101
Jackson, MS, 39216
Phone (601) 354-4836
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
52,509 services
Medicare patients, 2024
685
Average age 73
Drug cost, 2024
$980K
7,616 prescriptions
Company payments, 2025
$15K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Todd N Adkins was code J2182 (injection, mepolizumab, 1 mg), 19,500 times for 18 patients. In total Todd N Adkins billed 52,509 services in 42 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2182 Injection, mepolizumab, 1 mg | Office | 19,500 | 18 | $23.82 | $464K |
| J2357 Injection, omalizumab, 5 mg | Office | 12,315 | 20 | $29.81 | $367K |
| 95165 Treatment - Miscellaneous | Office | 5,825 | 250 | $8.60 | $50K |
| J1576 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 3,440 | 17 | $53.29 | $183K |
| 95004 Test - Miscellaneous | Office | 2,141 | 52 | $2.38 | $5,091 |
| 95115 Treatment - Miscellaneous | Office | 2,080 | 130 | $5.89 | $12K |
| 95044 Test - Miscellaneous | Office | 1,027 | 16 | $3.24 | $3,332 |
| 95117 Treatment - Miscellaneous | Office | 984 | 60 | $7.06 | $6,943 |
| 96372 Injection Administration | Office | 659 | 47 | $9.68 | $6,380 |
| 99214 Office E&M - Established | Office | 606 | 378 | $80.69 | $49K |
| 95024 Test - Miscellaneous | Office | 497 | 49 | $5.20 | $2,585 |
| 94010 Pulmonary Function Testing | Office | 359 | 235 | $16.96 | $6,089 |
| 99213 Office E&M - Established | Office | 246 | 221 | $54.71 | $13K |
| 96366 Intravenous Infusion, Hydration | Office | 115 | 20 | $13.60 | $1,565 |
| 95018 Test - Miscellaneous | Office | 110 | 12 | $13.65 | $1,502 |
By year: 2022 $846K for 41,724 services; 2023 $1.0M for 47,323 services; 2024 $1.3M for 52,509 services.
Medicare prescription drug claims, 2024
In 2024, the drug Todd N Adkins prescribed most often to Medicare patients was Montelukast Sodium, with 1,252 prescriptions and refills. In total Todd N Adkins wrote 7,616 Medicare prescriptions that cost $980K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,252 | 2,342 | 327 | $8,447 |
| Fluticasone Propionate Generic | 1,243 | 2,119 | 449 | $17K |
| Levocetirizine Dihydrochloride Generic | 929 | 1,520 | 242 | $15K |
| Azelastine Hcl Generic | 587 | 919 | 237 | $19K |
| Pantoprazole Sodium Generic | 351 | 637 | 86 | $2,439 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 341 | 387 | 142 | $11K |
| Prednisone Generic | 340 | 342 | 214 | $756 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 297 | 401 | 70 | $251K |
| Gabapentin Generic | 291 | 432 | 78 | $1,968 |
| Famotidine Generic | 279 | 422 | 65 | $2,927 |
| Ipratropium Bromide Generic | 185 | 269 | 67 | $6,999 |
| Breo Ellipta Fluticasone/Vilanterol | 151 | 193 | 38 | $74K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 135 | 159 | 35 | $16K |
| Hydroxyzine Hcl Generic | 125 | 190 | 47 | $1,886 |
| Cefdinir Generic | 73 | 73 | 59 | $1,256 |
Brand drugs: 1,167 claims; generic drugs: 6,449 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Todd N Adkins $15K ($15K in general payments such as food, travel and fees) from 21 companies. The largest payer was GlaxoSmithKline, LLC. with $8,678.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 31 | $8,678 |
| Genzyme Corporation SNY | 5 | $3,516 |
| Regeneron Healthcare Solutions, Inc. REGN | 24 | $612 |
| CSL Behring CSL.AX | 17 | $513 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $432 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $369 |
| Genentech USA, Inc. ROG.SW | 11 | $271 |
| Ionis Pharmaceuticals, Inc. IONS | 4 | $144 |
| LEO Pharma Inc. | 8 | $142 |
| Pfizer Inc. PFE | 5 | $116 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.